Literature DB >> 9218826

Antipolysaccharide antibodies in 450 children with otitis media.

S A Misbah1, H Griffiths, T Mitchell, A Freeland, M R Haeney, H M Chapel.   

Abstract

We have measured antibodies to pneumococcal and Haemophilus polysaccharides in a prospective study of 450 children aged 2-16 years with otitis media requiring grommets (ear tubes). Pneumococcal antibody levels were significantly higher in the 2-6 year (P < 0.004) and 7-10 year (P < 0.04) study groups in comparison with age-matched controls. There was no difference in Haemophilus antibody levels between the study and control group children for the age groups 2-6 years and 11-16 years. Haemophilus antibody levels were significantly lower in the 7-10 year (P < 0.003) group in comparison with age-matched controls. Eighty-eight out of 450 (19.6%) children had pneumococcal antibody levels below the 25th percentile. Nineteen out of 88 (21.6%) children with pneumococcal antibody levels below the 25th centile were test immunized with 23 valent Pneumococcal polysaccharide and unconjugated Haemophilus type b capsular polysaccharide. Of these 19 children (aged 4-11 years), five mounted suboptimal responses to both polysaccharide antigens, whilst one child failed to respond to Haemophilus polysaccharide alone. There was no significant difference in the prevalence of IgG subclass deficiency between the normal responders and poor responders to immunization (P = 0.12). We found no evidence of specific polysaccharide antibody deficiency in the vast majority of the 450 children studied. However, the significance of poor antibody responses to test immunization in a small minority of children with otitis media is unclear. Long-term follow up of these children is required to determine whether poor immunization responses herald the development of frank antibody deficiency.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9218826      PMCID: PMC1904702          DOI: 10.1046/j.1365-2249.1997.4291322.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  7 in total

Review 1.  Anti-pneumococcal antibody titre measurement: what useful information does it yield?

Authors:  Paul Balmer; Andrew J Cant; Ray Borrow
Journal:  J Clin Pathol       Date:  2006-09-01       Impact factor: 3.411

2.  The clinical syndrome of specific antibody deficiency in children.

Authors:  R J Boyle; C Le; A Balloch; M L-K Tang
Journal:  Clin Exp Immunol       Date:  2006-12       Impact factor: 4.330

3.  Atopic eczema is associated with delayed maturation of the antibody response to pneumococcal vaccine.

Authors:  P D Arkwright; L Patel; A Moran; M R Haeney; C I Ewing; T J David
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

4.  Development of an anti-Salmonella typhi Vi ELISA: assessment of immunocompetence in healthy donors.

Authors:  B L Ferry; S A Misbah; P Stephens; Z Sherrell; H Lythgoe; E Bateman; C Banner; J Jones; N Groome; H M Chapel
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

5.  The impact of an early truncating founder ATM mutation on immunoglobulins, specific antibodies and lymphocyte populations in ataxia-telangiectasia patients and their parents.

Authors:  A Stray-Pedersen; T Jónsson; A Heiberg; C R Lindman; E Widing; I S Aaberge; A L Borresen-Dale; T G Abrahamsen
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

Review 6.  Antibody deficiency in chronic rhinosinusitis: epidemiology and burden of illness.

Authors:  Christopher J Ocampo; Anju T Peters
Journal:  Am J Rhinol Allergy       Date:  2013-01       Impact factor: 2.467

7.  Immunodeficiency in ataxia telangiectasia is correlated strongly with the presence of two null mutations in the ataxia telangiectasia mutated gene.

Authors:  E R Staples; E M McDermott; A Reiman; P J Byrd; S Ritchie; A M R Taylor; E G Davies
Journal:  Clin Exp Immunol       Date:  2008-05-26       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.